CROs/Service Providers

Natus completes acquisition of Nicolet neurodiagnostic business

Tuesday, July 3, 2012 10:32 AM

Natus Medical, a San Carlos, Calif.-based provider of healthcare products, has completed the acquisition of the Nicolet neurodiagnostic business from CareFusion for an approximate $58 million cash.

More... »

Sorin Group acquires CalMed for $14M

Tuesday, July 3, 2012 10:14 AM

Sorin Group, a global medical device company with a focus on cardiovascular diseases, has acquired California Medical Laboratories (CalMed), a manufacturer of high quality cardiovascular cannulae, for $14 million.

More... »

Catalyst stockholders approve SXC merger

Tuesday, July 3, 2012 09:55 AM

Stockholders attending a special meeting for Catalyst Health Solutions, a fast-growing national pharmacy benefit management (PBM) company, have approved, among other things, the proposal to adopt the previously disclosed agreement and plan of merger with SXC Health Solutions, a Lisle, Ill.-based provider of PBM services and healthcare information technology solutions.

More... »

PharMerica introduces $25M share purchase program

Tuesday, July 3, 2012 09:22 AM

The board of directors of PharMerica, a national provider of institutional pharmacy and hospital pharmacy management services, has authorized an increase in its existing share purchase program that will allow the company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.

More... »

Pernix Therapeutics to acquire Great Southern Laboratories

Tuesday, July 3, 2012 09:08 AM

Pernix Therapeutics Holdings, a specialty pharmaceutical company of The Woodlands, Texas, has entered into a definitive agreement to acquire Great Southern Laboratories, a privately-held pharmaceutical contract manufacturing company of Houston, Texas.

More... »

Theradiag acquires Prestizia and microRNA technology platform

Monday, July 2, 2012 11:31 AM

Theradiag, a French theranostics and in vitro diagnostics company focused on autoimmune disease, has decided to acquire Prestizia, a French biotechnology company that develops microRNA technology.

More... »

ScinoPharm invests $37M in high potency cytotoxic injectable plant

Friday, June 29, 2012 02:50 PM

ScinoPharm, a Taiwanese provider of oncological APIs for injectable products, has decided to invest $37.6 million in the construction of a high potency cytotoxic injectable plant suitable for production of oncological injectable products on the company's premise at the Tainan Science Park.

More... »

Fluxion Biosciences, Stanford collaborate on circulating tumor cell analysis

Friday, June 29, 2012 11:45 AM

Fluxion Biosciences, a San Francisco-based provider of cellular analysis tools for use in critical life science, has formed a collaboration with the Stanford University School of Medicine to develop tests to help deliver more effective therapies to cancer patients.

More... »

Quotient Clinical, Capsugel collaborate on lipid-based formulations

Friday, June 29, 2012 11:23 AM

Quotient Clinical, a U.K. provider of specialist early stage drug development services, and Capsugel, a Morristown, N.J.-based provider of dosage solutions for the healthcare industry, have formed a collaboration to enable the rapid development and clinical assessment of lipid-based formulations. Together, the companies will use their technology and expertise to address the drug delivery challenges of poorly soluble molecules with limited oral bioavailability.

More... »

NERI nabs $18M NIH contract for pediatric circulatory support devices

Thursday, June 28, 2012 02:37 PM

New England Research Institutes (NERI), a privately held CRO that provides global, customized clinical trial solutions and registry services, has received an $18 million contract from the National Institutes of Health (NIH) for the PumpKIN Program for the development and clinical realization of novel pediatric circulatory support devices, such as ventricular assist devices (VADs) and extracorporeal membrane oxygenation devices (ECMOs).

More... »